Published in Aliment Pharmacol Ther on March 01, 2002
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Hemodynamic effects of one week of carvedilol administration on cirrhotic rats. J Gastroenterol (2006) 0.81
Gastrointestinal bleeding: Carvedilol-the best beta-blocker for primary prophylaxis? Nat Rev Gastroenterol Hepatol (2009) 0.81
The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis. Patient Prefer Adherence (2015) 0.80
Carvedilol in the treatment of portal hypertension. Saudi J Gastroenterol (2011) 0.77
Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis. BMJ Open (2016) 0.76
Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension. World J Hepatol (2017) 0.75
Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study. J Clin Exp Hepatol (2016) 0.75
A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. Am J Gastroenterol (2016) 0.75
Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography. Biomed Res Int (2017) 0.75
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Hepatic granulomas: a 10 year single centre experience. J Clin Pathol (2003) 1.30
Management of pyogenic liver abscesses - percutaneous or open drainage? Singapore Med J (2007) 1.24
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience. Am J Transplant (2010) 1.16
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol (1996) 1.12
The transjugular intrahepatic portosystemic shunt (TIPS). Clin Radiol (2009) 1.11
The patella as an unusual site of renal cell carcinoma metastasis. Singapore Med J (2007) 1.11
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
ALLEGED GONADOTROPIC EFFECT OF ROYAL JELLY. Science (1940) 1.09
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut (2008) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Adult right-lobe living liver donors: quality of life, attitudes and predictors of donor outcomes. Am J Transplant (2009) 1.07
Review article: the current management of acute liver failure. Aliment Pharmacol Ther (2009) 1.06
Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol (1996) 1.04
Faecal calprotectin in the assessment of Crohn's disease activity. QJM (2005) 1.04
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
The influence of captopril, the nitrates and propranolol on apparent liver blood flow. Br J Clin Pharmacol (1985) 1.04
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut (2003) 1.04
Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM (1998) 1.03
Review article: spontaneous bacterial peritonitis--diagnosis, treatment and prevention. Aliment Pharmacol Ther (2001) 1.01
Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology (2001) 1.01
Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.01
Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl (2000) 1.01
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl (2001) 1.01
A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther (1997) 1.00
Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther (2001) 1.00
Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis (1988) 1.00
Evidence of hydrogen ion secretion from the human gall bladder in vitro. Gut (1992) 0.99
Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. QJM (2002) 0.99
Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. QJM (1994) 0.98
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
The management of alcoholic hepatitis: a prospective comparison of scoring systems. Aliment Pharmacol Ther (2013) 0.97
Review article: the management of acute liver failure. Aliment Pharmacol Ther (1998) 0.97
Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet (1995) 0.96
Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther (2006) 0.96
Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM (2010) 0.95
Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther (2000) 0.95
Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis (1998) 0.95
Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet (1995) 0.94
A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res (2000) 0.94
Review article: quantitative tests of liver function. Aliment Pharmacol Ther (1995) 0.94
The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes. Biochim Biophys Acta (2001) 0.94
Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol (2000) 0.93
The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol (1998) 0.93
A passive haemagglutination (TRC) inhibitor in thyrotoxic serum. Clin Endocrinol (Oxf) (1979) 0.93
The liver in typhoid fever: always affected, not just a complication. Am J Gastroenterol (1991) 0.92
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy. Aliment Pharmacol Ther (2014) 0.92
The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. Clin Radiol (2011) 0.92
Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet (1991) 0.91
Plasma glutathione S-transferase measurements in patients with alcoholic cirrhosis. Clin Chim Acta (1987) 0.91
Restriction of color in the rat with associated sterility in the male and heterochromia in both sexes. J Exp Zool (1972) 0.90
Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. J Hepatol (1999) 0.90
Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft. FASEB J (1998) 0.90
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut (2005) 0.89
Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet (2001) 0.89
Glutathione S-transferase in human bile. Clin Chim Acta (1989) 0.89
Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response. Blood (1996) 0.88
Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24-hour heart rate variability. Am J Gastroenterol (1994) 0.88
Coeliac disease presenting as variceal haemorrhage. Gut (2003) 0.88
Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1995) 0.88
Pseudohermaphrodite rat: end organ insensitivity to testosterone. Science (1970) 0.87
Glutathione S-transferases in alcoholic liver disease. Gut (1990) 0.87
Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol (1996) 0.87
The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol (1999) 0.87